Advertisement
Screener

Keros Therapeutics, Inc. (KROS) Pre-Tax Margin

Keros Therapeutics, Inc. (KROS) Pre-Tax Margin

  • 2026-03-31: Pre-Tax Margin -6459.95%.
  • 2025-12-31: Pre-Tax Margin -6487.01%.
  • 2025-09-30: Pre-Tax Margin -61.03%.
  • 2025-06-30: Pre-Tax Margin -181.19%.

Complete source-backed pre-tax margin history.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-03-31-6459.95%
2025-12-31-6487.01%
2025-09-30-61.03%
2025-06-30-181.19%
2025-03-3175.03%
2024-12-31-1503.16%
2024-09-30-13648.45%
2024-06-30-122316.22%
2024-03-31-51944.58%
2021-12-31-24.70%
2021-06-30-15622.00%
2019-12-31-110.04%
2019-09-30-141.96%
2019-06-30-114.12%
2019-03-31-127.32%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3137.65%
2024-12-31-5269.10%
2023-12-31-101319.21%
2021-12-31-282.25%
2019-12-31-123.36%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73